*Edited by René Mauricio Barría*

Infant and neonatal health is one of the areas of greatest development and evolution within pediatrics. This edited volume Update on Critical Issues in Infant and Neonatal Care is a collection of reviewed and relevant research chapters offering a comprehensive overview of recent developments in six topics about common newborn and infant health problems. In 6 chapters that address relevant issues about infant and neonatal care, the book seeks to contribute to the clinical work of the health teams of critical care units. Specialists in the field of pediatrics from different countries have developed these chapters and through them they hope to share part of their experience.

ISBN 978-1-78985-361-2

Update on Critical Issues on Infant and Neonatal Care

Published in London, UK © 2020 IntechOpen © TatyanaMishchenko / iStock


**Advanced Materials for Societal Implementation**

Editors

**Hideyuki Kanematsu Yoshikazu Todaka Takaya Sato**

MDPI Basel Beijing Wuhan Barcelona Belgrade Manchester Tokyo Cluj Tianjin

*Editors* Hideyuki Kanematsu Collaborative Research Promotion Center National Institute of Technology (KOSEN), Suzuka College Suzuka Japan

Yoshikazu Todaka Department of Mechanical Engineering Toyohashi University of Technology Toyohashi, Aichi Japan

Takaya Sato President National Institute of Technology (KOSEN), Okinawa College Nago, Okinawa Japan

*Editorial Office* MDPI St. Alban-Anlage 66 4052 Basel, Switzerland

This is a reprint of articles from the Special Issue published online in the open access journal *Materials* (ISSN 1996-1944) (available at: www.mdpi.com/journal/materials/special issues/ KOSEN ISATE2021 materials).

For citation purposes, cite each article independently as indicated on the article page online and as indicated below:

LastName, A.A.; LastName, B.B.; LastName, C.C. Article Title. *Journal Name* **Year**, *Volume Number*, Page Range.

**ISBN 978-3-0365-6132-5 (Hbk) ISBN 978-3-0365-6131-8 (PDF)**

© 2023 by the authors. Articles in this book are Open Access and distributed under the Creative Commons Attribution (CC BY) license, which allows users to download, copy and build upon published articles, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications.

The book as a whole is distributed by MDPI under the terms and conditions of the Creative Commons license CC BY-NC-ND.


**2. Epidemiology**

#### **2.1. Incubation period**

EI is characterized by an incubation period of 5 days a maximum and an infective period of 14 days. An incubation period of 2–3 days has been observed in susceptible horse populations during severe epidemics in the field. In naive horses, the incubation period can be less than 24 h [35] and virus excretion may persist for 7–10 days [36]. Most shedding occurs in the early stages of clinical disease when coughing is most pronounced. In partially immune horses showing no clinical signs or mild clinical signs, virus shedding may occur.

#### **2.2. Interspecies transmission of equine influenza viruses**

There are three types of influenza viruses: A, B and C, but only the first has a very high propensity to crossing species barrier, the two others being found almost exclusively in humans. Influenza A viruses met in several species including birds, humans, swine, horses, marine mammals and dogs. Only a restricted number of sub‐type combinations have become established in mammalian species (H7N7 and H3N8 in horses; H1N1, H3N2 and H2N2 in humans) [37]. Recently, two distinct lineages (H17N10 and H18N11) of influenza A virus have been derived from bats. This discovery provided novel insights into the origin and evolution of influenza A viruses beyond the predominant hypothesis of waterfowls/shorebirds as the primary natural reservoir.

The equine influenza virus infects horses and other equids (such as donkeys, mules and zebras) can, but rarely affects other species (such as dogs) [38]. Studies have shown that the H3N8 sub‐ type was introduced into horses a long time ago and the lack of exchange of virus genes between the equine viruses and viruses from other species [39] led to the suggestion that horses may be a 'dead‐end' host. However, in Florida (US) at the beginning of 2004, equine influenza virus has been associated with outbreaks of respiratory disease in dogs (primarily but not exclusively, greyhounds) in North America, quarry hounds in England and dogs on premises with horses affected by influenza in Australia in 2007 [40–44]. Interspecies transmission of equine influenza virus to dogs upon close contact with experimentally infected horses was demonstrated [45]. To date, there is no documented evidence on the transmission of equine influenza virus from dogs to horses [46].

During 2004–2006 swine influenza surveillance in central China, two equine H3N8 influenza viruses were isolated from pigs [47]. Pigs have both sialic acid (SA) a2‐3 galactose and a2‐6 galactose containing receptors on cell surfaces. However, in vivo infection experiments on mini‐pigs demonstrated that equine influenza virus failed to induce pyrexia, appreciable histopathological lesions or virus shedding [1]. The H3 HA has broad pathogenic potential but analysis of the HA genes of influenza A viruses suggests that the equine and canine H3 have evolved separately to the H3 of avian, human and swine viruses [48].

It is generally accepted that there is a correlation between receptor binding characteristics and host specificity of equine influenza viruses. For influenza viruses to enter host cells, the HA glycoprotein must bind to sialic acid receptors on the cell surface. Viruses isolated from wild aquatic birds bind strongly to SA in a 2,3‐linkage (SA 2,3). The same linkage is recognised by equine influenza virus and is the predominant linkage found on cells lining the equine upper respiratory tract. In contrast, human‐adapted influenza viruses recognise and bind SA 2,6 receptors, and these are the receptors that predominate in the human respiratory tract [37]. Virus shedding and seroconversions were recorded in human volunteers inoculated with equine influenza virus [49] but although the potential for such transmission is demonstrable, there is no evidence that horses are reservoirs of virus for humans.

It is equally possible that a new influenza sub‐type could emerge in horses from the avian reservoir. Although it did not replace the current equine H3N8 virus that has been circulating in horses for many years [39], cross‐species transmission of avian H3N8 influenza virus into horses occurred in Jilin Province in China during 1989. The genetic analysis of the strain responsible of this outbreak (A/equine 2/Jilin 89) indicated was more closely related to avian influenza viruses than to other equine H3N8 influenza viruses [50, 51]. This strain (A/equine 2/Jilin 89) did not appear to persist in the horse population after 1990 or to spread beyond China to other countries. This transient re‐emergence of the H3N8 subtype rather than any other may reflect the fact that this sub‐type is commonly isolated from the avian reservoir [52]. More recently, avian H5N1 has been associated with respiratory disease in donkeys in Egypt [2]. This detection described a new subtype of highly contagious avian influenza virus as an equine infectious agent, and raises questions about the role of donkey in the spread of H5N1 virus to birds, humans and other mammals including equines.

#### **2.3. Spread and transmission of equine influenza viruses**

each of Clades 1 and 2 of the Florida sublineage. The Clade 1 is represented by A/equine/South Africa/4/2003‐like or A/equine/Ohio/2003‐like viruses. The Clade 2 is represented by A/equine/

22 Epidemiology of Communicable and Non-Communicable Diseases - Attributes of Lifestyle and Nature on Humankind

EI is characterized by an incubation period of 5 days a maximum and an infective period of 14 days. An incubation period of 2–3 days has been observed in susceptible horse populations during severe epidemics in the field. In naive horses, the incubation period can be less than 24 h [35] and virus excretion may persist for 7–10 days [36]. Most shedding occurs in the early stages of clinical disease when coughing is most pronounced. In partially immune horses

There are three types of influenza viruses: A, B and C, but only the first has a very high propensity to crossing species barrier, the two others being found almost exclusively in humans. Influenza A viruses met in several species including birds, humans, swine, horses, marine mammals and dogs. Only a restricted number of sub‐type combinations have become established in mammalian species (H7N7 and H3N8 in horses; H1N1, H3N2 and H2N2 in humans) [37]. Recently, two distinct lineages (H17N10 and H18N11) of influenza A virus have been derived from bats. This discovery provided novel insights into the origin and evolution of influenza A viruses beyond the predominant hypothesis of waterfowls/shorebirds as the

The equine influenza virus infects horses and other equids (such as donkeys, mules and zebras) can, but rarely affects other species (such as dogs) [38]. Studies have shown that the H3N8 sub‐ type was introduced into horses a long time ago and the lack of exchange of virus genes between the equine viruses and viruses from other species [39] led to the suggestion that horses may be a 'dead‐end' host. However, in Florida (US) at the beginning of 2004, equine influenza virus has been associated with outbreaks of respiratory disease in dogs (primarily but not exclusively, greyhounds) in North America, quarry hounds in England and dogs on premises with horses affected by influenza in Australia in 2007 [40–44]. Interspecies transmission of equine influenza virus to dogs upon close contact with experimentally infected horses was demonstrated [45]. To date, there is no documented evidence on the transmission of equine

During 2004–2006 swine influenza surveillance in central China, two equine H3N8 influenza viruses were isolated from pigs [47]. Pigs have both sialic acid (SA) a2‐3 galactose and a2‐6 galactose containing receptors on cell surfaces. However, in vivo infection experiments on mini‐pigs demonstrated that equine influenza virus failed to induce pyrexia, appreciable histopathological lesions or virus shedding [1]. The H3 HA has broad pathogenic potential but

showing no clinical signs or mild clinical signs, virus shedding may occur.

**2.2. Interspecies transmission of equine influenza viruses**

Richmond/1/2007‐like viruses.

**2. Epidemiology**

**2.1. Incubation period**

primary natural reservoir.

influenza virus from dogs to horses [46].

Influenza is primarily a seasonal disease usually occurring in epidemic form, often rampant in waves, followed by periods of relative calm. EIV is highly contagious and is primarily spread by the respiratory route through direct contact between infectious and susceptible horses in close proximity. In unvaccinated, susceptible horses, the short incubation period and persistent coughing which releases large amounts of virus into the environment contribute to the rapid spread of the infection. Personnel and fomites also contribute to virus spread. In the absence of release of horses from the quarantine station, it was concluded that the virus escaped on the person, clothing or equipment of a groom, veterinarian, farrier or someone else who had contact with the infected horses and left the station without implementing adequate biosecur‐ ity measures. The contaminated vehicles were implicated in the spread of the virus [20, 53]. Severe outbreaks of equine influenza occur in unimmunized populations of horses or when a new strain infects a vaccinated population. In a susceptible group of horses, morbidity can be as high as 100%. Horses stabled under intensive conditions are at risk from a build‐up of infective virus in the common airspace. The global distribution of the EIV is associated with increased movement of horses participating in competitions or for breeding or sale. In the first outbreak of equine influenza in Australia in 2007, the initial spread of the virus in the general horse population, then spread to the Thoroughbred population, it was estimated that over 75,000 horses had been infected. In the Japanese outbreak, in the same year, the reverse situation pertained, the initial outbreaks were in racehorses and the virus then spread to the non‐Thoroughbred population. In the second confirmed outbreak of respiratory disease in Algeria in 2011 since 1972, the disease occurred in a variety of locations and stud farms among Thoroughbred and non‐Thoroughbred horse populations. Around 900 horses have been affected during this outbreak which led to race cancellation in the whole country for 2 months [15]. During the outbreak in Uruguay in 2012, which affected over 2000 horses, race meetings were cancelled for several weeks and movement of horses out of the country was prohibited. Equine influenza outbreaks also resulted in the cancellation of equestrian events in Brazil [27].

#### **2.4. Mortality to EIV**

Mortality is very rarely associated with equine influenza but a small number of fatalities have been reported in young foals from non‐vaccinated mares; thus, inadequate passive transfer of antibodies, due to poor‐quality colostrum or inadequate intake, is likely to be a major factor. All mares should be vaccinated adequately to ensure that there are sufficient maternally derived antibodies in colostrum [54, 55]. Deaths of those foals as a result of acutely viral pneumonia, and in affected donkeys and horses that are not adequately rested. In northeastern China in 1989, a mortality rate of up to 20% in some herds was associated with a large outbreak of equine influenza. More than 40 horses died during an outbreak affecting over 74,000 horses in Mongolia in 2011 [32]. Disconcertingly, several foal deaths were also reported during EI outbreaks in France during 2012 [56].

#### **2.5. Factors influencing transmission**

Although equine influenza virus spread is frequently explosive in naïve populations, the majority of outbreaks in endemic populations are contained with limited spread between premises. Outbreaks are often associated with the introduction of new horses to premises [17], and seronegative horses are frequently the index cases [57]. Although the index cases may not be the source of the virus, they act to amplify the virus and serve as a source of infection to other horses in the cohort. The severity of the disease depends on the immune status of the horse (naive, partially immunized or immunosuppressive), on the infecting viral dose, virulence of the virus strain and to the inoculation route. However, antigenic variants can give rise to large‐scale disease epidemics such as occurred in 1979–1981 in Europe and in North America [58, 59]. Mismatch between vaccine and infecting strains requires higher levels of antibodies to prevent infection and significantly increases the risk of an outbreak at the population level [60, 61]. Introduction of subclinical affected vaccinated horses in a susceptible population is also a major contributing factor to influenza outbreaks, in South Africa in 1986, India in 1987, Europe in 1989, Croatia in 2004, Italy in 2005 and also suspected in Australia in 2007. In general, young horses, horses with low serum antibody titres and those that are highly mobile and mix with large groups of horses are considered most at risk [15, 62]. However, in the 2003 outbreak in Newmarket, 2‐year‐old horses were less susceptible than older horses despite having accounted for any differences in antibody levels [63]. Finally, a few studies demonstrated that the sex as a risk factor for influenza infection.

#### **2.6. Survival and persistence of EIV**

outbreak of equine influenza in Australia in 2007, the initial spread of the virus in the general horse population, then spread to the Thoroughbred population, it was estimated that over 75,000 horses had been infected. In the Japanese outbreak, in the same year, the reverse situation pertained, the initial outbreaks were in racehorses and the virus then spread to the non‐Thoroughbred population. In the second confirmed outbreak of respiratory disease in Algeria in 2011 since 1972, the disease occurred in a variety of locations and stud farms among Thoroughbred and non‐Thoroughbred horse populations. Around 900 horses have been affected during this outbreak which led to race cancellation in the whole country for 2 months [15]. During the outbreak in Uruguay in 2012, which affected over 2000 horses, race meetings were cancelled for several weeks and movement of horses out of the country was prohibited. Equine influenza outbreaks also resulted in the cancellation of equestrian events in Brazil [27].

24 Epidemiology of Communicable and Non-Communicable Diseases - Attributes of Lifestyle and Nature on Humankind

Mortality is very rarely associated with equine influenza but a small number of fatalities have been reported in young foals from non‐vaccinated mares; thus, inadequate passive transfer of antibodies, due to poor‐quality colostrum or inadequate intake, is likely to be a major factor. All mares should be vaccinated adequately to ensure that there are sufficient maternally derived antibodies in colostrum [54, 55]. Deaths of those foals as a result of acutely viral pneumonia, and in affected donkeys and horses that are not adequately rested. In northeastern China in 1989, a mortality rate of up to 20% in some herds was associated with a large outbreak of equine influenza. More than 40 horses died during an outbreak affecting over 74,000 horses in Mongolia in 2011 [32]. Disconcertingly, several foal deaths were also reported during EI

Although equine influenza virus spread is frequently explosive in naïve populations, the majority of outbreaks in endemic populations are contained with limited spread between premises. Outbreaks are often associated with the introduction of new horses to premises [17], and seronegative horses are frequently the index cases [57]. Although the index cases may not be the source of the virus, they act to amplify the virus and serve as a source of infection to other horses in the cohort. The severity of the disease depends on the immune status of the horse (naive, partially immunized or immunosuppressive), on the infecting viral dose, virulence of the virus strain and to the inoculation route. However, antigenic variants can give rise to large‐scale disease epidemics such as occurred in 1979–1981 in Europe and in North America [58, 59]. Mismatch between vaccine and infecting strains requires higher levels of antibodies to prevent infection and significantly increases the risk of an outbreak at the population level [60, 61]. Introduction of subclinical affected vaccinated horses in a susceptible population is also a major contributing factor to influenza outbreaks, in South Africa in 1986, India in 1987, Europe in 1989, Croatia in 2004, Italy in 2005 and also suspected in Australia in 2007. In general, young horses, horses with low serum antibody titres and those that are highly mobile and mix with large groups of horses are considered most at risk [15, 62]. However, in the 2003 outbreak in Newmarket, 2‐year‐old horses were less susceptible than older horses

**2.4. Mortality to EIV**

outbreaks in France during 2012 [56].

**2.5. Factors influencing transmission**

The equine influenza virus has a lipid envelope and does not survive for long outside the horse. It is fragile and easily inactivated by exposure to ultraviolet light for 30 min, by heating at 50°C for 30 min, by ether and by acid (pH 3). Exposure to sunlight for 15 min at 15°C also inactivates the virus. The virus will not survive long in the environment in conditions of high humidity [64].

The virus can however survive on skin, fabrics and the surfaces of contaminated equipment for some time. The periods of survival are shorter in conditions of higher humidity. Studies have also shown that the virus may be transferred from stainless steel surfaces to hands and from paper tissues to hands.

Equine influenza is a self‐limiting disease and the virus does not persist in recovered horses. It is thought that influenza persists in endemic populations by low‐grade circulation with occasional small outbreaks [65]. In countries where equine influenza appears not to be endemic and quarantine measures are implemented, there is no evidence of long‐term persistence following sporadic incursions. In Australia in 2007, the disease was eradicated within 4 months following the implementation of an extensive control programme [66].

No information is available about the persistence of EI virus in horse carcases. Virus could be expected to be present in the carcases of animals that die during the viraemic phase of infection.

### **3. Conclusion**

Equine influenza A H3N8 viruses continue to cause serious diseases in horses despite control measures, including quarantine and vaccination, and the international spread of the virus occurs during exchanges and participation horses in competitions. Moreover, monitoring antigenic drift and emergence of new strains that allow the production of effective vaccines is critical. Finally, the vaccination of horses by modern and effective vaccines will considered to be a new weapon to control this disease.


**1. Introduction**

Marine algal polysaccharides are an important nutrient source for marine bacteria. To utilize these polysaccharides, which significantly differ from terrestrial plant ones, marine bacteria have developed unusual degradation mechanisms. Key players in the degradation of complex polysaccharides are the marine *Flavobacteriia* of the phylum *Bac-teroidetes* [1,2]. The microorganisms feature different polysaccharide utilization loci (PULs), which encode a set of enzymes and other proteins involved in the breakdown of specific polysaccharides. The first recognized PULs were alginolytic operons associated with alginate utilization in marine *Bacteroidetes* [3]. The current studies of PULs are based on the sequencing of the genomes of cultured bacteria and metagenomes as a valuable resource of CAZymes and CAZyme machineries [4–10], allowing us to expand our knowledge of the bacterial degradation of algal polysaccharides.

The major bacterial players in marine polysaccharide degradation have become the subject of extensive research studies using genomic and transcriptomic approaches. Representatives of the genus *Zobellia* are marine *Flavobacteriia* and they specialize in algal polysaccharide degradation. The genus *Zobellia* was proposed by Barbeyron et al. (2001) [11]. First, the genus included two species: *Zobellia galactanivorans* and *Zobellia uliginosa*. Later, three new species were added [12]: *Zobellia russellii*, *Zobellia laminariae*, and *Zobellia amurskyensis*. To date, the five species of the genus *Zobellia* have validly published names (as listed at https://lpsn.dsmz.de/genus/zobellia, February 2021), and all originate from marine environments.

Members of the *Zobellia* genus are frequently found associated with red and brown algae [13]. *Z. galactanivorans* DsijT, a marine species isolated from a red alga, was chosen as the type species [11]. Its genome exhibits a number of adaptive features such as consumption of algal polysaccharides, resistance to algal defense, and large amounts of CAZymes and sulfatases [14]. Numerous biochemical and structural studies have begun to unveil the

**Citation:** Chernysheva, N.; Bystritskaya, E.; Likhatskaya, G.; Nedashkovskaya, O.; Isaeva, M. Genome-Wide Analysis of PL7 Alginate Lyases in the Genus *Zobellia*. *Molecules* **2021**, *26*, 2387. https:// doi.org/10.3390/molecules26082387

Academic Editor: Changsheng Zhang

Received: 11 March 2021 Accepted: 15 April 2021 Published: 20 April 2021

**Publisher's Note:** MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

**Copyright:** © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).

complex enzyme systems for the degradation of various polysaccharides, such as agars, carrageenans, and laminarin [3,15–21].

In this work, we have applied genome-based approaches to investigate PL7 alginate lyases across the *Zobellia* genus.


**3. Sedation levels**

In recent years, four levels of sedation have been established that extend along a spectrum without clear limits: minimal sedation or anxiolysis, moderate sedation, deep sedation, and general anesthesia [1]. These sedation levels have been characterized by the reaction of a patient to verbal, light contact, or painful stimuli, although they are often associated with physiological changes in vital patient signs.

"Minimal sedation" is also known as anxiolysis and is defined as the lowest drug-induced stage of cognition-impairment. Individuals who are minimally sedated usually respond to simple orders and their breathing/cardiovascular

system is unaffected. Oral benzodiazepines are commonly used to achieve minimal sedatives.

"Moderate Sedation" has traditionally been referred to as "Conscious Sedation". This entitles a deeper depression consciousness level. Individuals who are moderately sedated can still respond to verbal orders, often requiring physical stimulation, and their breathing/cardiovascular function is unaffected. Intravenous benzodiazepines and opioids are examples of drugs used to achieve moderate sedation.

'Deep sedation' leads to major depression of the central nervous system, where patients are no longer conscious and are more difficult to arouse. They will usually respond to painful stimuli but not to verbal or simple tactile stimuli. The respiratory system is stressed and some ventilatory assistance may be required.

Intravenous benzodiazepines, intravenous anesthetics such as propofol, ketamine, etomidate, and dexmedetomidine are examples of medicines used for deep sedation.

'General anesthesia' is the deepest type of sedation in which there is a total lack of consciousness and no response to stimuli. Cardiovascular and respiratory functions are often compromised, therefore, monitoring and assistance, such as ventilatory support, may be needed.

A fifth level/form of sedation, also known as 'Dissociative sedation is a variant of moderate sedation characteristically produced by a medication class known as phencyclidine, such as ketamine, which induces a disconnection between the thalamo-neocortical system and the limbic structures, preventing sensory stimuli from being received by higher centers [2, 3].


**5. Conclusions**

Gene expression in the immune system is tightly regulated by epigenetic processes, including DNA methylation, chromatin remodeling and histone modifications, that orchestrate development, maturation and cell lineage commitment. In line with this, specific DNA methylation signatures and histone modification patterns can be detected for each cell population.

Next-generation sequencing technologies have enabled the identification of several new forms of IEI, surprisingly changing the scenario and expanding the knowledge of their molecular basis. Nonetheless, a genetic etiology still needs to be elucidated for many of them; hence, it is reasonable that alterations to the epigenetic mechanisms that control the transcription of genes involved in immune response may contribute to the pathogenesis of at least some of these disorders.

In addition, although most genetic IEIs are paradigmatic examples of monogenic disorders, a broad spectrum of severity and clinical phenotypes is widely recognized. Therefore, epigenetic signatures may be implicated in the regulation of disease expressivity and penetrance, possibly expanding the phenotype.

**Author Contributions:** R.R., G.G, A.R., N.B.-P. and C.P. conceived and designed the review; R.R., G.G., F.C., C.M., L.P., C.N., E.T., E.C. (Emma Coppola), A.D.R. and E.C. (Emilia Cirillo) wrote the paper; R.R. and F.C. created the figure; A.R. and C.P. supervised the Review. All authors have read and agreed to the published version of the manuscript.

**Funding:** This work was supported by the Ministero della Salute (RF 2016-02364303).

**Institutional Review Board Statement:** Not applicable.

**Informed Consent Statement:** Not applicable.

**Data Availability Statement:** Not applicable.

**Conflicts of Interest:** The authors declare no conflict of interest.

#### **References**


**5. Remarks and perspectives**

The particle size differences could influence the roughness surface of PMMA without decreasing their mechanical properties. Furthermore, studies should continue to determine that issue in detail.

Ultrasound can be used to process the acrylic resin (Opticryl®) as an alternative technique for PMMA processing with similar results to those obtained using water bath or microwave processing (control groups).

The addition of antifungal agents on PMMA surface or into PMMA, such as moieties, metallic or metallic oxide nanoparticles, and antibiotics, could be useful for the inhibition of specific pathogens such as *Candida albicans* for prosthodontic denture.

Residual monomer leach induces cytotoxic and inflammatory reactions of oral cells and tissues in contact with the acrylic resin. It is suggested that water or ethanol bath after polymerization of acrylic resin could decrease the cytotoxic and toxicity activity against oral cells and tissues. But ultrasonic waves are a good option for both, for thermopolymerization of PMMA and at the same time to reduce the residual monomer.


**Wick Debinding – An Effective Way of Solving Problems in the Debinding Process of Powder Injection Molding**

Lovro Gorjan  *Jožef Stefan Institute, Research and Development Center for Ignition Systems and Electronics d.o.o., Slovenia*


**Taxonomic Principles**

bacteria in the field of Microbiology, Biotechnology, Biomedical Science, Plant Science, Agri‐

The book comprises a total of 16 chapters from multiple contributors around the world, in‐ cluding Brazil, South Africa, Saudi Arabia, Colombia, India, China, Mexico, and the United States. We are grateful to all the contributors and leading experts for the submission of their stimulating and inclusive chapters in the preparation of the edited volume to bring the book on Actinobacteria basics and biotechnological applications. We offer our special thanks and appreciation to Ms. Ana Pantar and Ms. Sandra Bakic, Publishing Process Manager, for their

We express our heartfelt gratitude to Prof. Cheng-Lin Jiang, Key Laboratory for Microbial Resources of Ministry of Education, Yunnan Institute of Microbiology, Yunnan University, Kunming, Yunnan 650091, P.R. China, for his valuable conceptual suggestions and proof comments during the review process of this book. Appreciations are due to my research scholars, Ms. S. Latha, Ms A. Ranjani, and Ms. G. Vinothini, for their sincere efforts and dili‐ gence toward this book. We are also indebted to InTech-Open Science, Bharathidasan Uni‐ versity, and Yunnan University for their concern, efforts, and support in the task of

Actinobacteria hold a prominent position as targets in screening programs due to versity and their proven ability to produce novel metabolites. They are nowned as secondary metabolite producers and hence are of high pharmacological commercial interest. Approximately, 23,000 microbial secondary metabolites dous economic importance have been identified so far, in which 12,000 compounds duced by Actinobacteria. Interestingly, 7600 bioactive compounds are reported from members of the genus Streptomyces with antibacterial, antifungal, antiviral, antihelminthic, antialgal, antimalarial, anticancer, anti-inflammatory, antithrombotic, X Preface

Actinobacteria hold a prominent position as targets in screening programs due to their di‐ versity and their proven ability to produce novel metabolites. They are universally re‐ nowned as secondary metabolite producers and hence are of high pharmacological and commercial interest. Approximately, 23,000 microbial secondary metabolites with tremen‐ dous economic importance have been identified so far, in which 12,000 compounds are pro‐ duced by Actinobacteria. Interestingly, 7600 bioactive compounds are reported from the members of the genus Streptomyces with antibacterial, antifungal, antiviral, antiprotozoan, antihelminthic, antialgal, antimalarial, anticancer, anti-inflammatory, antithrombotic, and

**Dr. Dharumadurai Dhanasekaran**

Bharathidasan University,

India

**Dr. Yi Jiang**

P. R. China

Yunnan University,

Department of Microbiology, School of Life Sciences,

Yunnan Institute of Microbiology, School of Life Science,

culture, Plant pathology, Environmental Science, etc.

publishing this volume.

VIII Preface

encouragement and help in bringing out the book in the present form.